tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Panacea Biotec Announces 41st AGM Details and Compliance Measures

Story Highlights
  • Panacea Biotec operates in biotechnology, focusing on pharmaceuticals and vaccines.
  • The company announced its 41st AGM notice, emphasizing compliance and shareholder engagement.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Panacea Biotec Announces 41st AGM Details and Compliance Measures

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Panacea Biotec Limited ( (IN:PANACEABIO) ) has shared an update.

Panacea Biotec Limited announced the publication of a newspaper notice regarding its 41st Annual General Meeting, including details about the cut-off date and remote e-voting. This announcement is part of the company’s compliance with SEBI regulations, ensuring transparency and shareholder engagement in its governance processes.

More about Panacea Biotec Limited

Panacea Biotec Limited is a company operating in the biotechnology and pharmaceutical industry. It is primarily involved in the development, manufacturing, and marketing of pharmaceutical formulations and vaccines, focusing on providing healthcare solutions to improve global health.

Average Trading Volume: 16,386

Technical Sentiment Signal: Buy

Current Market Cap: 24.91B INR

See more insights into PANACEABIO stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1